| 000 | 01434 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514012016.0 | ||
| 264 | 0 | _c20020124 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0271-0749 | ||
| 024 | 7 |
_a10.1097/00004714-200110000-00007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMøller, S E | |
| 245 | 0 | 0 |
_aLack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects. _h[electronic resource] |
| 260 |
_bJournal of clinical psychopharmacology _cOct 2001 |
||
| 300 |
_a493-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAnticonvulsants _xblood |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aCarbamazepine _xblood |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aCitalopram _xblood |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolypharmacy |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xblood |
| 700 | 1 | _aLarsen, F | |
| 700 | 1 | _aKhant, A Z | |
| 700 | 1 | _aRolan, P E | |
| 773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 21 _gno. 5 _gp. 493-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004714-200110000-00007 _zAvailable from publisher's website |
| 999 |
_c11513196 _d11513196 |
||